Literature DB >> 14681758

Moyamoya and extracranial vascular involvement: fibromuscular dysplasia? A report of two children.

R R de Vries1, P G J Nikkels, J van der Laag, G Broere, K P J Braun.   

Abstract

We present two patients with moyamoya syndrome and the unusual involvement of extracranial vessels. The first case illustrates the rare association between moyamoya and primary pulmonary hypertension. In the second patient, moyamoya was complicated by stenoses of vertebral, renal, and mesenteric arteries. In both cases, a systemic intima-proliferative disease, such as fibromuscular dysplasia (FMD), was suspected to be the cause of both intracranial and extracranial arterial disease.

Entities:  

Mesh:

Year:  2003        PMID: 14681758     DOI: 10.1055/s-2003-44664

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

1.  Cerebrovascular Complications of Fibromuscular Dysplasia.

Authors:  Megan C. Leary; Anna Finley; Louis R. Caplan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

2.  Patients with Moyamoya Vasculopathy Evaluated at a Single-Center in The Netherlands; Clinical Presentation and Outcome.

Authors:  Annick Kronenburg; Rachel Kleinloog; Albert van der Zwan; L Jaap Kappelle; Luca Regli; Kees P J Braun; Catharina J M Klijn
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

Review 3.  Pulmonary hypertension's variegated landscape: a snapshot.

Authors:  Thomas J Kulik; Eric D Austin
Journal:  Pulm Circ       Date:  2017-03-13       Impact factor: 3.017

Review 4.  Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.

Authors:  Yuting Luo; Zhixin Cao; Shaoqing Wu; Xunsha Sun
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

5.  Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease.

Authors:  Tae Keun Jee; Je Young Yeon; Sung Mok Kim; Oh Young Bang; Jong-Soo Kim; Seung-Chyul Hong
Journal:  J Am Heart Assoc       Date:  2020-09-21       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.